| Literature DB >> 35706556 |
Monal Depani1, Andrew E Grush2,3, Matthew J Parham2,3, Lloyd M Jones2,3, James F Thornton1.
Abstract
Oncologic reconstruction of the nose and scalp following Mohs micrographic surgery poses a significant challenge for plastic surgeons. While these defects are traditionally reconstructed using primary closure techniques, skin grafts, local flaps, pedicled flaps, and free tissue transfer, the incorporation of biologic healing wound agents such as Integra and Cytal provides patients and surgeons with alterative reconstructive options without additional donor site morbidity. Herein, we review the use of biologic agents used in soft tissue reconstruction of the nose and scalp following Mohs surgery. Thieme. All rights reserved.Entities:
Keywords: Mohs surgery; acellular dermis; biologics; plastic surgery; wounds and injuries
Year: 2022 PMID: 35706556 PMCID: PMC9192160 DOI: 10.1055/s-0042-1742750
Source DB: PubMed Journal: Semin Plast Surg ISSN: 1535-2188 Impact factor: 2.195